Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro.

Mesquida M, Drawnel F, Lait PJ, Copland DA, Stimpson ML, Llorenç V, Sainz de la Maza M, Adan A, Widmer G, Strassburger P, Fauser S, Dick AD, Lee RWJ, Molins B.

Transl Vis Sci Technol. 2019 Oct 28;8(5):32. doi: 10.1167/tvst.8.5.32. eCollection 2019 Sep.

2.

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.

Atienza-Mateo B, Martín-Varillas JL, Calvo-Río V, Demetrio-Pablo R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adan A, Hernández MV, Hernández-Garfella M, Valls-Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, García-Serrano JL, Ortego-Centeno N, Herreras JM, Fonollosa A, Garcia-Aparicio ÁM, Maíz-Alonso O, Blanco A, Torre-Salaberri I, Fernandez-Espartero C, Jovaní V, Peiteado D, Pato E, Cruz J, Férnandez-Cid C, Aurrecoechea E, García-Arias M, Castañeda S, Caracuel-Ruiz MA, Montilla-Morales CA, Atanes-Sandoval A, Francisco F, Insua S, González-Suárez S, Sanchez-Andrade A, Gamero F, Linares Ferrando LF, Romero-Bueno F, García-González AJ, González RA, Muro EM, Carrasco-Cubero C, Olive A, Prior Á, Vázquez J, Ruiz-Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernandez S, Fernández-Carballido C, Rubio-Romero E, Pages FA, Toyos-Sáenz de Miera FJ, Martinez MG, Díaz-Valle D, López Longo FJ, Nolla JM, Álvarez ER, Martínez MR, González-López JJ, Rodríguez-Cundin P, Hernández JL, González-Gay MA, Blanco R.

Arthritis Rheumatol. 2019 Jun 25. doi: 10.1002/art.41026. [Epub ahead of print]

PMID:
31237427
3.

The role of inflammation in diabetic eye disease.

Mesquida M, Drawnel F, Fauser S.

Semin Immunopathol. 2019 Jul;41(4):427-445. doi: 10.1007/s00281-019-00750-7. Epub 2019 Jun 7. Review.

PMID:
31175392
4.

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.

Matas J, Llorenç V, Fonollosa A, Esquinas C, Diaz-Valle D, Berasategui B, Mesquida M, Artaraz J, Rios J, Adan A.

PLoS One. 2019 Jan 24;14(1):e0210799. doi: 10.1371/journal.pone.0210799. eCollection 2019.

5.

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.

Vegas-Revenga N, Calvo-Río V, Mesquida M, Adán A, Hernández MV, Beltrán E, Valls Pascual E, Díaz-Valle D, Díaz-Cordovés G, Hernandez-Garfella M, Martínez-Costa L, Calvo I, Atanes A, Linares LF, Modesto C, González-Vela C, Demetrio-Pablo R, Aurrecoechea E, Cordero M, Domínguez-Casas LC, Atienza-Mateo B, Martín-Varillas JL, Loricera J, Palmou-Fontana N, Hernández JL, González-Gay MA, Blanco R.

Am J Ophthalmol. 2019 Apr;200:85-94. doi: 10.1016/j.ajo.2018.12.019. Epub 2019 Jan 17.

PMID:
30660771
6.

Antituberculous Treatment Itself Might Prevent Visual Impairment in Presumed Tuberculosis-Related Uveitis.

Llorenç V, Benejam G, Mesquida M, Sainz de la Maza M, Molins B, Alba C, Pelegrin L, Martínez JA, Adán A.

Ocul Immunol Inflamm. 2018 Nov 5:1-8. doi: 10.1080/09273948.2018.1541326. [Epub ahead of print]

PMID:
30395738
7.

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.

Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, Salom D, Ortego N, García-Serrano JL, Callejas-Rubio JL, Herreras JM, García-Aparicio Á, Maíz O, Blanco A, Torre I, Díaz-Valle D, Pato E, Aurrecoechea E, Caracuel MA, Gamero F, Minguez E, Carrasco-Cubero C, Olive A, Vázquez J, Ruiz-Moreno O, Manero J, Muñoz-Fernández S, Martinez MG, Rubio-Romero E, Toyos-Sáenz de Miera FJ, López Longo FJ, Nolla JM, Revenga M, González-Vela C, Loricera J, Atienza-Mateo B, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.

Ophthalmology. 2018 Sep;125(9):1444-1451. doi: 10.1016/j.ophtha.2018.02.020. Epub 2018 Mar 27. Erratum in: Ophthalmology. 2019 Jan;126(1):177.

PMID:
29602570
8.

Reply.

Mesquida M, Llorenc V, Adan A.

Med Clin (Barc). 2018 Oct 23;151(8):336-337. doi: 10.1016/j.medcli.2018.02.005. Epub 2018 Mar 7. English, Spanish. No abstract available.

PMID:
29525112
9.

Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.

Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15. Review.

10.

Targeting interleukin-6 in autoimmune uveitis.

Mesquida M, Molins B, Llorenç V, de la Maza MS, Adán A.

Autoimmun Rev. 2017 Oct;16(10):1079-1089. doi: 10.1016/j.autrev.2017.08.002. Epub 2017 Aug 2. Review.

PMID:
28778705
11.

New imaging techniques in retinal vasculitis.

Mesquida M, Llorens V, Adán A.

Med Clin (Barc). 2017 Sep 20;149(6):261-266. doi: 10.1016/j.medcli.2017.05.009. Epub 2017 Jul 5. Review. English, Spanish.

PMID:
28687121
12.

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A.

Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690.

PMID:
28520640
13.

Bacillus Calmette-Guérin Infection and Cytotoxicity in the Retinal Pigment Epithelium.

Llorenç V, Mesquida M, Molins B, González-Martín J, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2018;26(5):786-792. doi: 10.1080/09273948.2016.1265655. Epub 2016 Dec 23.

PMID:
28010156
14.

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J.

Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21.

15.

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.

Santos-Gómez M, Calvo-Río V, Blanco R, Beltrán E, Mesquida M, Adán A, Cordero-Coma M, García-Aparicio ÁM, Valls Pascual E, Martínez-Costa L, Hernández MV, Hernandez Garfella M, González-Vela MC, Pina T, Palmou-Fontana N, Loricera J, Hernández JL, González-Gay MA.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S34-S40. Epub 2016 Apr 7.

PMID:
27054359
16.

Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.

Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López-Montesinos B, Mesquida M, Adán A, Hernández MV, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.

Arthritis Rheumatol. 2017 Mar;69(3):668-675. doi: 10.1002/art.39940.

17.

Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.

Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.

J Rheumatol. 2016 Dec;43(12):2183-2188. Epub 2016 Sep 15.

PMID:
27633821
18.

In Response to: "Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment".

Mesquida M, Llorenç V, Adán A.

Ocul Immunol Inflamm. 2017 Apr;25(2):221-222. doi: 10.3109/09273948.2016.1145240. Epub 2016 Mar 25. No abstract available.

PMID:
27014943
19.

Interleukin-22 serum levels are elevated in active scleritis.

Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenç V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS.

Acta Ophthalmol. 2016 Sep;94(6):e395-9. doi: 10.1111/aos.13005. Epub 2016 Mar 24.

20.

Elevated Serum Immune Mediators and Subclinical Inflammation in HLA-A29-associated Birdshot Chorioretinopathy.

Molins B, Mesquida M, Llorenç V, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2016 Dec;24(6):647-652. Epub 2015 Dec 8.

PMID:
26645126

Supplemental Content

Loading ...
Support Center